These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia. Hocepied AM; Falkson CI; Falkson G S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555 [TBL] [Abstract][Full Text] [Related]
29. Fludarabine and prednisone in pretreated and refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages. De Rossi G; Mauro FR; Caruso R; Monarca B; Mandelli F Haematologica; 1993; 78(3):167-71. PubMed ID: 8375746 [TBL] [Abstract][Full Text] [Related]
31. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia. Laurenti L; Piccioni P; Tarnani M; De Padua L; Garzia M; Efremov DG; Piccirillo N; Chiusolo P; Sica S; Leone G Leuk Res; 2007 Feb; 31(2):253-6. PubMed ID: 16815546 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial. Dearden CE; Richards S; Else M; Catovsky D; Hillmen P Cancer; 2011 Jun; 117(11):2452-60. PubMed ID: 24048793 [TBL] [Abstract][Full Text] [Related]
33. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome]. Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485 [TBL] [Abstract][Full Text] [Related]
34. Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. Mauro FR; Molica S; Laurenti L; Cortelezzi A; Carella AM; Zaja F; Chiarenza A; Angrilli F; Nobile F; Marasca R; Musolino C; Brugiatelli M; Piciocchi A; Vignetti M; Fazi P; Gentile G; De Propris MS; Della Starza I; Marinelli M; Chiaretti S; Del Giudice I; Nanni M; Albano F; Cuneo A; Guarini A; Foà R; Leuk Res; 2014 Feb; 38(2):198-203. PubMed ID: 24314589 [TBL] [Abstract][Full Text] [Related]
35. [Experience with fludarabine treatment and review of the literature]. Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643 [TBL] [Abstract][Full Text] [Related]
36. Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia. Vaisban E; Zaina A; Braester A; Manaster J; Horn Y Ann Hematol; 2001 May; 80(5):314-5. PubMed ID: 11446738 [TBL] [Abstract][Full Text] [Related]
37. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987 [TBL] [Abstract][Full Text] [Related]
38. Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations. Tambaro FP; Wierda WG Lancet Haematol; 2020 Feb; 7(2):e168-e176. PubMed ID: 32004486 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of oral fludarabine in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Zhu Y; Qin Q; Xie Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 38(3):221-4. PubMed ID: 23545817 [TBL] [Abstract][Full Text] [Related]